Press release
Stem Cell Mobilization Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Tev
"Stem Cell Mobilization Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Stem Cell Mobilization Market.
The Stem Cell Mobilization Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Stem Cell Mobilization Pipeline Report: https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Stem Cell Mobilization treatment therapies with a considerable amount of success over the years.
• Stem Cell Mobilization companies working in the treatment market are Magenta Therapeutics, BioLineRx, and others, are developing therapies for the Stem Cell Mobilization treatment
• Emerging Stem Cell Mobilization therapies in the different phases of clinical trials are- AVA4746, Balixafortide, Burixafor, MGTA 145, Motixafortide, and others are expected to have a significant impact on the Stem Cell Mobilization market in the coming years.
• In December 2023, BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical company specializing in transformative therapies within oncology and rare diseases, has announced the initiation of the Phase 1 clinical trial. This trial aims to evaluate motixafortide, both as a standalone treatment and in combination with natalizumab, for mobilizing CD34+ hematopoietic stem cells (HSC) used in gene therapies targeting sickle cell disease (SCD). The proof-of-concept trial, in partnership with Washington University School of Medicine in St. Louis, has dosed its initial patient and plans to enroll a total of five SCD patients. The primary focus is to assess the safety and tolerance levels of both treatment regimens.
• In April 2023, BioLineRx, Ltd. has commenced a trial named "A Pilot Safety and Feasibility Study to Assess the Use of Motixafortide (CXCR4/SDF-1 Inhibition) and Natalizumab (VLA-4/VCAM-1 Inhibition) as an Innovative Approach to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD).
• In June 2022, BioLineRx Ltd. has revealed a partnership with GenFleet Therapeutics, a China-based biopharmaceutical company specializing in immuno-oncology. This collaboration aims to progress Motixafortide through a randomized Phase II b clinical trial focusing on pancreatic ductal adenocarcinoma (PDAC).
Stem Cell Mobilization Overview
Stem cell mobilization is a medical process designed to encourage stem cells, which are typically located in the bone marrow, to move from the bone marrow into the bloodstream. This process is often employed before stem cell transplantation, allowing for the collection of stem cells from the blood for therapeutic purposes.
Get a Free Sample PDF Report to know more about Stem Cell Mobilization Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Stem Cell Mobilization Molecule Type
Stem Cell Mobilization Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Stem Cell Mobilization Pipeline Therapeutics Assessment
• Stem Cell Mobilization Assessment by Product Type
• Stem Cell Mobilization By Stage and Product Type
• Stem Cell Mobilization Assessment by Route of Administration
• Stem Cell Mobilization By Stage and Route of Administration
• Stem Cell Mobilization Assessment by Molecule Type
• Stem Cell Mobilization by Stage and Molecule Type
DelveInsight's Stem Cell Mobilization Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Stem Cell Mobilization product details are provided in the report. Download the Stem Cell Mobilization pipeline report to learn more about the emerging Stem Cell Mobilization therapies at:
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Stem Cell Mobilization Therapeutics Market include:
Key companies developing therapies for Stem Cell Mobilization are - Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Teva Pharmaceuticals, Gilead Sciences, Merck & Co., Bristol Myers Squibb, and others.
Stem Cell Mobilization Pipeline Analysis:
The Stem Cell Mobilization pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Stem Cell Mobilization with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Stem Cell Mobilization Treatment.
• Stem Cell Mobilization key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Stem Cell Mobilization Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Stem Cell Mobilization market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Stem Cell Mobilization drugs and therapies-
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Stem Cell Mobilization Pipeline Market Drivers
• Increase in prevalence of Solid Tumors, novel pathways being explored in animal and early human studies are some of the important factors that are fueling the Stem Cell Mobilization Market.
Stem Cell Mobilization Pipeline Market Barriers
• However, high cost of therapy, challenges associated with the analysis of genetic factors responsible for the great variability in mobilization responses, poor Understanding of the mechanisms underlying the process of HSPC mobilization and other factors are creating obstacles in the Stem Cell Mobilization Market growth.
Scope of Stem Cell Mobilization Pipeline Drug Insight
• Coverage: Global
• Key Stem Cell Mobilization Companies: Magenta Therapeutics, BioLineRx, and others
• Key Stem Cell Mobilization Therapies: AVA4746, Balixafortide, Burixafor, MGTA 145, Motixafortide, and others
• Stem Cell Mobilization Therapeutic Assessment: Stem Cell Mobilization current marketed and Stem Cell Mobilization emerging therapies
• Stem Cell Mobilization Market Dynamics: Stem Cell Mobilization market drivers and Stem Cell Mobilization market barriers
Request for Sample PDF Report for Stem Cell Mobilization Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/stem-cell-mobilization-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Stem Cell Mobilization Report Introduction
2. Stem Cell Mobilization Executive Summary
3. Stem Cell Mobilization Overview
4. Stem Cell Mobilization- Analytical Perspective In-depth Commercial Assessment
5. Stem Cell Mobilization Pipeline Therapeutics
6. Stem Cell Mobilization Late Stage Products (Phase II/III)
7. Stem Cell Mobilization Mid Stage Products (Phase II)
8. Stem Cell Mobilization Early Stage Products (Phase I)
9. Stem Cell Mobilization Preclinical Stage Products
10. Stem Cell Mobilization Therapeutics Assessment
11. Stem Cell Mobilization Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Stem Cell Mobilization Key Companies
14. Stem Cell Mobilization Key Products
15. Stem Cell Mobilization Unmet Needs
16 . Stem Cell Mobilization Market Drivers and Barriers
17. Stem Cell Mobilization Future Perspectives and Conclusion
18. Stem Cell Mobilization Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Stem Cell Mobilization Epidemiology https://www.delveinsight.com/report-store/stem-cell-mobilization-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Stem Cell Mobilization Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Lung Transplant Rejection Market https://www.delveinsight.com/report-store/lung-transplant-rejection-market
DelveInsight's "Lung Transplant Rejection Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Lung Transplant Rejection, historical and forecasted epidemiology as well as the Lung Transplant Rejection market trends in the United States, EU4 (Germany, France, Italy, Spain), and the United Kingdom, and Japan.
CAR T-Cell Therapy for Multiple Myeloma Market
https://www.delveinsight.com/report-store/car-t-cell-therapy-for-multiple-myeloma-market
DelveInsight's "CAR-T Cell Therapy for Multiple Myeloma Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of multiple myeloma and various CAR-Ts used in multiple myeloma, and CAR-Ts historical and forecasted market trends in multiple myeloma in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Insulin Resistance Market
https://www.delveinsight.com/report-store/insulin-resistance-market
DelveInsight's "Insulin Resistance Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Insulin Resistance, historical and forecasted epidemiology as well as the Insulin Resistance market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Dyskinesia Market
https://www.delveinsight.com/report-store/dyskinesia-market
DelveInsight's "Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dyskinesia, historical and forecasted epidemiology as well as the Dyskinesia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemophilia Market
https://www.delveinsight.com/report-store/hemophilia-market
DelveInsight's "Hemophilia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemophilia, historical and forecasted epidemiology as well as the Hemophilia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Paroxysmal Nocturnal Hemoglobinuria Market
https://www.delveinsight.com/report-store/paroxysmal-nocturnal-hemoglobinuria-market
DelveInsight's 'Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of Paroxysmal Nocturnal Hemoglobinuria historical and forecasted epidemiology as well as the Paroxysmal Nocturnal Hemoglobinuria market trends in the United States, the EU4 (Germany, France, Italy, Spain), the UK and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stem Cell Mobilization Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Sanofi, Amgen, BioLineRx Ltd, Genzyme (a Sanofi company), Novartis, Pfizer, Tev here
News-ID: 3345858 • Views: …
More Releases from DelveInsight Business Research
Spasticity Clinical Pipeline 2025: A Comprehensive Review of 12+ Emerging Therap …
According to DelveInsight's latest analysis, the global Spasticity pipeline features more than 10 active pharmaceutical companies that are advancing over 12 investigational therapies. The report offers a detailed evaluation of clinical trials, mechanisms of action, therapeutic approaches, routes of administration, and major developmental activities shaping the Spasticity treatment landscape.
DelveInsight's report, "Spasticity Pipeline Insight, 2025," delivers an extensive overview of the current clinical development environment and the future outlook for the…
Real-World Evidence Solution Market is set to grow at a 8.07% CAGR, reaching USD …
According to DelveInsight, the real-world evidence (RWE) solutions market is expanding rapidly, primarily due to the increasing global burden of chronic diseases and the growing need to improve healthcare outcomes. In addition, advancements in big data analytics, artificial intelligence, and machine learning are enhancing the ability to efficiently process and interpret large-scale real-world datasets. The rising adoption of RWE solutions by pharmaceutical and biotechnology companies - to support drug development,…
Spinal Implants Market is set to grow at a 5.50% CAGR, reaching USD 21.9 billion …
According to DelveInsight's assessment, the rising burden of spinal disorders particularly within the growing elderly population - continues to significantly increase the demand for surgical correction procedures. Alongside this, the surge in sports-related injuries and trauma cases is accelerating the need for advanced implantable spinal solutions. There is also a notable shift toward non-fusion and motion-preserving devices that support spinal flexibility and enhance patient outcomes, especially for younger and more…
Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billio …
According to DelveInsight's assessment, the rising global burden of cancer is significantly increasing the demand for advanced treatment approaches such as tumor ablation. Minimally invasive ablation techniques are gaining strong traction due to their advantages, including faster recovery times, lower complication risks, and reduced costs compared with traditional surgical procedures. At the same time, continuous improvements in ablation technologies - particularly in radiofrequency, microwave, and cryoablation systems - have enhanced…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
